Dr. Javier Pinilla-Ibarz, MD, PhD
Claim this profileMoffitt Cancer Center
Area of expertise
Chronic Lymphocytic Leukemia
Javier Pinilla-Ibarz, MD, PhD has run 2 trials for Chronic Lymphocytic Leukemia. Some of their research focus areas include:
Diffuse Large B-Cell Lymphoma
Javier Pinilla-Ibarz, MD, PhD has run 2 trials for Diffuse Large B-Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
H. Lee Moffitt Cancer Center And Research Institute
Moffitt Cancer Center
More about Javier Pinilla-Ibarz, MD, PhD
Clinical Trial Related
6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Javier Pinilla-Ibarz, MD, PhD has experience with
- PRGN-3007
- BCR-ABL Tyrosine Kinase Inhibitor (TKI)
- Ruxolitinib
- Ibrutinib
- YTB323
Breakdown of trials Javier Pinilla-Ibarz, MD, PhD has run
Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma
Acute Lymphoblastic Leukemia
Non-Hodgkin's Lymphoma
Mantle Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Javier Pinilla-Ibarz, MD, PhD specialize in?
Javier Pinilla-Ibarz, MD, PhD focuses on Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Chronic Lymphocytic Leukemia has involved MYC positive patients, or patients who are BCL2 positive.
Is Javier Pinilla-Ibarz, MD, PhD currently recruiting for clinical trials?
No, Javier Pinilla-Ibarz, MD, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Javier Pinilla-Ibarz, MD, PhD has studied deeply?
Yes, Javier Pinilla-Ibarz, MD, PhD has studied treatments such as PRGN-3007, BCR-ABL Tyrosine Kinase Inhibitor (TKI), Ruxolitinib.
What is the best way to schedule an appointment with Javier Pinilla-Ibarz, MD, PhD?
Apply for one of the trials that Javier Pinilla-Ibarz, MD, PhD is conducting.
What is the office address of Javier Pinilla-Ibarz, MD, PhD?
The office of Javier Pinilla-Ibarz, MD, PhD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.